EpiVario Secures Exclusive Worldwide License for Novel Technologies...

Company acquires full rights, in all fields, for novel drug to treat memory-related psychiatric disorders, such as post-traumatic stress disorder (PTSD)(PRWeb January 16, 2019)Read the full story at https://www.prweb.com/releases/epivario_secures_exclusive_worldwide_license_for_novel_technologies_and_drugs_for_memory_related_psychiatric_diseases_from_university_of_pennsylvania/prweb16032994.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news